AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
Development of distamycin-related DNA binding anticancer drugs
Authors: Marchini, S Broggini, M Sessa, C D'Incalci, M
Citation: S. Marchini et al., Development of distamycin-related DNA binding anticancer drugs, EXPERT OP I, 10(9), 2001, pp. 1703-1714
Synthesis of aplyolide A, ichthyotoxic macrolide isolated from the skin ofthe marine mollusk Aplysia depilans
Authors: Spinella, A Caruso, T Martino, M Sessa, C
Citation: A. Spinella et al., Synthesis of aplyolide A, ichthyotoxic macrolide isolated from the skin ofthe marine mollusk Aplysia depilans, SYNLETT, (12), 2001, pp. 1971-1973
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
Authors: Crivellari, D Pagani, O Veronesi, A Lombardi, D Nole, F Thurlimann, B Hess, D Borner, M Bauer, J Martinelli, G Graffeo, R Sessa, C Goldhirsch, A
Citation: D. Crivellari et al., High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel, ANN ONCOL, 12(3), 2001, pp. 353-356
Risk factors of atherosclerosis and saphenous vein endothelial function
Authors: Sessa, C Morasch, MD Friedland, M Kline, RA
Citation: C. Sessa et al., Risk factors of atherosclerosis and saphenous vein endothelial function, INT ANGIOL, 20(2), 2001, pp. 152-163
Phase I-II study of escalating doses of amifostine combined with high-dosecyclophosphamide
Authors: Ghielmini, M Van der Bosch, S Bosshard, M Pampallona, S Gabutti, L Egger, HP Kiess, M Cavalli, F Sessa, C
Citation: M. Ghielmini et al., Phase I-II study of escalating doses of amifostine combined with high-dosecyclophosphamide, CANC CHEMOT, 47(6), 2001, pp. 532-536
Role of duplex imaging in endovenous obliteration for primary venous insufficiency
Authors: Pichot, O Sessa, C Chandler, JG Nuta, M Perrin, M
Citation: O. Pichot et al., Role of duplex imaging in endovenous obliteration for primary venous insufficiency, J ENDOVAS T, 7(6), 2000, pp. 451-459
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
Authors: Sessa, C Capri, G Gianni, L Peccatori, F Grasselli, G Bauer, J Zucchetti, M Vigano, L Gatti, A Minoia, C Liati, P Van den Bosch, S Bernareggi, A Camboni, G Marsoni, S
Citation: C. Sessa et al., Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex, ANN ONCOL, 11(8), 2000, pp. 977-983
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study
Authors: Pagani, O Sessa, C Nole, F Crivellari, D Lombardi, D Thurlimann, B Hess, D Borner, M Bauer, J Martinelli, G Graffeo, R Zucchetti, M D'Incalci, M Goldhirsch, A
Citation: O. Pagani et al., Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I-II study, ANN ONCOL, 11(8), 2000, pp. 985-991
Activity and toxicity of GI147211 in breast, colorectal and non-small-celllung cancer patients: An EORTC-ECSG phase II clinical study
Authors: Gamucci, T Paridaens, R Heinrich, B Schellens, JH Pavlidis, N Verweij, J Sessa, C Kaye, S Roelvink, M Wanders, J Hanauske, A
Citation: T. Gamucci et al., Activity and toxicity of GI147211 in breast, colorectal and non-small-celllung cancer patients: An EORTC-ECSG phase II clinical study, ANN ONCOL, 11(7), 2000, pp. 793-797
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer
Authors: De Pas, T de Braud, F Danesi, R Sessa, C Catania, C Curigliano, G Fogli, S del Tacca, M Zampino, G Sbanotto, A Rocca, A Cinieri, S Marrocco, E Milani, A Goldhirsch, A
Citation: T. De Pas et al., Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer, ANN ONCOL, 11(7), 2000, pp. 821-827
Proposing phase I studies: Patients', relatives', nurses' and specialists'perceptions
Authors: Tomamichel, M Jaime, H Degrate, A de Jong, J Pagani, O Cavalli, F Sessa, C
Citation: M. Tomamichel et al., Proposing phase I studies: Patients', relatives', nurses' and specialists'perceptions, ANN ONCOL, 11(3), 2000, pp. 289-294
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG)
Authors: Sessa, C Wanders, J Roelvink, M Dombernowsky, P Nielsen, D Morant, R Drings, P Wissel, P Hanauske, AR
Citation: C. Sessa et al., Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG), ANN ONCOL, 11(2), 2000, pp. 207-210
Prevalence and consequences of nutritional depletion in lung transplant candidates
Authors: Schwebel, C Pin, I Barnoud, D Devouassoux, G Brichon, PY Chaffanjon, P Chavanon, O Sessa, C Blin, D Guignier, M Leverve, X Pison, C
Citation: C. Schwebel et al., Prevalence and consequences of nutritional depletion in lung transplant candidates, EUR RESP J, 16(6), 2000, pp. 1050-1055
Critical hand ischemia after angioaccess surgery: Diagnosis and treatment
Authors: Sessa, C Pecher, M Maurizi-Balzan, J Pichot, O Tonti, F Farah, I Magne, JL Guidicelli, H
Citation: C. Sessa et al., Critical hand ischemia after angioaccess surgery: Diagnosis and treatment, ANN VASC S, 14(6), 2000, pp. 583-593
Management of symptomatic and asymptomatic popliteal venous aneurysms: A retrospective analysis of 25 patients and review of the literature
Authors: Sessa, C Nicolini, P Perrin, M Farah, I Magne, JL Guidicelli, H
Citation: C. Sessa et al., Management of symptomatic and asymptomatic popliteal venous aneurysms: A retrospective analysis of 25 patients and review of the literature, J VASC SURG, 32(5), 2000, pp. 902-911
Management of symptomatic and asymptomatic popliteal venous aneurysms: A retrospective analysis of 25 patients and review of the literature - Discussion
Authors: Pearce, WH Sessa, C
Citation: Wh. Pearce et C. Sessa, Management of symptomatic and asymptomatic popliteal venous aneurysms: A retrospective analysis of 25 patients and review of the literature - Discussion, J VASC SURG, 32(5), 2000, pp. 912-912
Defining the role of extended saphenofemoral junction ligation: A prospective comparative study
Authors: Chandler, JG Pichot, O Sessa, C Schuller-Petrovic, S Osse, FJ Bergan, JJ
Citation: Jg. Chandler et al., Defining the role of extended saphenofemoral junction ligation: A prospective comparative study, J VASC SURG, 32(5), 2000, pp. 941-952
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer
Authors: Neijt, JP Engelholm, SA Tuxen, MK Sorensen, PG Hansen, M Sessa, C de Swart, CAM Hirsch, FR Lund, B van Houwelingen, HC
Citation: Jp. Neijt et al., Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer, J CL ONCOL, 18(17), 2000, pp. 3084-3092
Cyclosporine A and Cremophor EL induce contractions of human saphenous vein: Involvement of thromboxane A(2) receptor-dependent pathway
Authors: Hardy, G Stanke-Labesque, F Deveaux, G Devillier, P Sessa, C Bessard, G
Citation: G. Hardy et al., Cyclosporine A and Cremophor EL induce contractions of human saphenous vein: Involvement of thromboxane A(2) receptor-dependent pathway, J CARDIO PH, 36(6), 2000, pp. 693-698
Vasoconstrictor effects of iso-prostaglandin F-2 alpha type-III (8-iso-prostaglandin F-2 alpha) on human saphenous veins
Authors: Gardan, B Cracowski, JL Sessa, C Hunt, M Stanke-Labesque, F Devillier, P Bessard, G
Citation: B. Gardan et al., Vasoconstrictor effects of iso-prostaglandin F-2 alpha type-III (8-iso-prostaglandin F-2 alpha) on human saphenous veins, J CARDIO PH, 35(5), 2000, pp. 729-734
Treatment of primary venous insufficiency by endovenous saphenous vein obliteration
Authors: Chandler, JG Pichot, O Sessa, C Schuller-Petrovic, S Kabnick, LS Bergan, JJ
Citation: Jg. Chandler et al., Treatment of primary venous insufficiency by endovenous saphenous vein obliteration, VASC SURG, 34(3), 2000, pp. 201-214
Classical (HIV-negative) cutaneous Kaposi's sarcoma: a case report and a short review of the literature
Authors: Sanna, P Rosselli, M Mainetti, C Gilliet, F Sessa, C Bernier, J Cavalli, F
Citation: P. Sanna et al., Classical (HIV-negative) cutaneous Kaposi's sarcoma: a case report and a short review of the literature, SCHW MED WO, 130(26), 2000, pp. 988-992
Adenocarcinoma of the rete testis
Authors: Spataro, V Caldiera, S Rusca, T Sessa, C Cavalli, F
Citation: V. Spataro et al., Adenocarcinoma of the rete testis, J UROL, 164(4), 2000, pp. 1307-1308
Inframelleolar arterial bypass for limb salvage. Late results.
Authors: Farah, I Penillon, S Sessa, C Bosson, JL Martin, M Chichignoud, B Magne, JL Guidicelli, H
Citation: I. Farah et al., Inframelleolar arterial bypass for limb salvage. Late results., ANN CHIR, 125(5), 2000, pp. 450-456
Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients
Authors: Cerny, T Leyvraz, S von Briel, T Kupfer, A Schaad, R Schmitz, SFH Honegger, P Sessa, C Brunner, J Boddy, AV
Citation: T. Cerny et al., Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients, ANN ONCOL, 10(9), 1999, pp. 1087-1094
Risultati: 1-25 | 26-45